Na II - Search Results

1

Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma.

Yun T, Lee KW, Song EG, Na II, Shin HC, Yoon SS, Park SY, Kim BK, Lee JH, Choi SJ, Lee JH, Lee KH. Yun T, et al. Among authors: na ii. Clin Transplant. 2007 May-Jun;21(3):337-43. doi: 10.1111/j.1399-0012.2007.00646.x. Clin Transplant. 2007. PMID: 17488382

2

A pilot study of bortezomib in Korean patients with relapsed or refractory myeloma.

Lee KW, Yun T, Song EK, Na II, Shin H, Bang SM, Lee JH, Lee ST, Kim JH, Yoon SS, Lee JS, Park S, Kim BK, Kim NK. Lee KW, et al. Among authors: na ii. J Korean Med Sci. 2005 Aug;20(4):598-62. doi: 10.3346/jkms.2005.20.4.598. J Korean Med Sci. 2005. PMID: 16100450 Free PMC article. Clinical Trial.

3

Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.

Lee KW, Im SA, Yun T, Song EK, Na Ii, Shin H, Choi IS, Oh DY, Kim JH, Kim DW, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Lee KW, et al. Among authors: na ii. Jpn J Clin Oncol. 2005 Dec;35(12):720-6. doi: 10.1093/jjco/hyi198. Epub 2005 Dec 6. Jpn J Clin Oncol. 2005. PMID: 16332718 Clinical Trial.

4

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer.

Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Lee KW, et al. Among authors: na ii. J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S115-21. doi: 10.3346/jkms.2007.22.S.S115. J Korean Med Sci. 2007. PMID: 17923737 Free PMC article. Clinical Trial.

5

Kim HR, Kang MS, Na II, Yang SH, Choi YH, Kang HJ, Kim CH, Lee JC. Kim HR, et al. Among authors: na ii. J Cancer Res Clin Oncol. 2010 Apr;136(4):547-52. doi: 10.1007/s00432-009-0687-0. Epub 2009 Sep 30. J Cancer Res Clin Oncol. 2010. PMID: 19789893

6

EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.

Na II, Kang HJ, Cho SY, Koh JS, Lee JK, Lee BC, Lee GH, Lee YS, Yoo HJ, Ryoo BY, Yang SH, Shim YS. Na II, et al. Eur J Cancer. 2007 Feb;43(3):520-6. doi: 10.1016/j.ejca.2006.09.025. Epub 2007 Jan 16. Eur J Cancer. 2007. PMID: 17224267

7

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.

Na II, Rho JK, Choi YJ, Kim CH, Park JH, Koh JS, Ryoo BY, Yang SH, Lee JC. Na II, et al. Lung Cancer. 2007 Jul;57(1):96-102. doi: 10.1016/j.lungcan.2007.01.027. Epub 2007 Mar 6. Lung Cancer. 2007. PMID: 17337084

8

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.

Na II, Rho JK, Choi YJ, Kim CH, Koh JS, Ryoo BY, Yang SH, Lee JC. Na II, et al. J Korean Med Sci. 2007 Jun;22(3):393-9. doi: 10.3346/jkms.2007.22.3.393. J Korean Med Sci. 2007. PMID: 17596643 Free PMC article.

9

18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.

Na II, Byun BH, Kang HJ, Cheon GJ, Koh JS, Kim CH, Choe DH, Ryoo BY, Lee JC, Lim SM, Yang SH. Na II, et al. Clin Cancer Res. 2008 Apr 1;14(7):2036-41. doi: 10.1158/1078-0432.CCR-07-4074. Clin Cancer Res. 2008. PMID: 18381942

10

A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer.

Na II, Lee TH, Choe DH, Cheon GJ, Kim CH, Koh JS, Baek H, Ryoo BY, Yang SH, Lee JC. Na II, et al. Eur J Cancer. 2008 Nov;44(16):2411-7. doi: 10.1016/j.ejca.2008.07.003. Epub 2008 Aug 15. Eur J Cancer. 2008. PMID: 18707868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters